Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.00    0.00 (0.00%)
Bid:
64.00
Ask:
65.80
Spread: 1.80 (2.812%)
Market Cap: £110.02m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Investment Completions and C Share Conversion

3 Oct 2016 10:00

RNS Number : 4843L
Project Finance Investments Limited
03 October 2016
 

Project Finance Investments Limited

(the "Company")

Investment completions of c. £16.8 million

16 and 20 year asset backed loans

 

The Company is pleased to announce that it has made a 16 year loan in an amount of up to £12.8 million to finance the construction and operation of a care home which, upon completion in 2017/18, will comprise c. 67 units.

The loan is secured by way of first ranking charges against the property and has been funded from the proceeds of the Company's recent issue of C Shares.

Moreover the Company has invested c. £4.0 million of the proceeds of the Company's recent issue of C Shares in additional tranches of the c. 20 year loan note secured against social housing units leased by housing associations in England which was announced on 1 March 2016 and which was initially subscribed in an amount of c. £4.2 million.

The Company has now invested substantially all of the proceeds of the recent C share issue in accordance with its investment policy and consequently the conversion of the C shares will take place in accordance with the provisions of the Articles, as summarised in the prospectus dated 27 April 2016.

It is currently expected that conversion will occur in accordance with the following timetable:

Conversion Calculation Date

Announcement of Conversion Ratio

30 September

14 October 2016

Conversion Date

18 October 2016

 

Dealings in the new ordinary shares arising on conversion are currently expected to commence, and the listing of the C shares to be cancelled, at 8.00 am on 18 October 2016.

 

On this basis the Company will make an application for the new ordinary shares to be admitted to the Official List and to trading on the London Stock Exchange from the same time and date.

 

This announcement contains inside information.

For further information, please contact: -

Gravis Capital Partners LLP 

David Conlon

david.conlon@gcpuk.com

+44 (0)20 7518 1490

Stephen Ellis

Stephen.ellis@gcpuk.com

 

Dion Di Miceli

dion.dimiceli@gcpuk.com

 

 

Cenkos Securities plc

Tom Scrivens

tscrivens@cenkos.com

+44 (0)20 7397 1915

Sapna Shah

sshah@cenkos.com

+44 (0)20 7397 1922

 

Buchanan

Charles Ryland +44 (0)20 7466 5000

Victoria Hayns

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CONMJBPTMBIMMPF
Date   Source Headline
2nd Jun 20267:37 amRNSDisposal of care home loan portfolio
22nd May 202612:00 pmRNSResults of Annual General Meeting
29th Apr 20265:45 pmRNSDividend Declaration
15th Apr 20269:30 amRNSNotice of Annual General Meeting
31st Mar 20267:00 amRNSAnnual Report and Accounts
19th Feb 20267:00 amRNSInvestor report at 31 December 2025
2nd Feb 20267:00 amRNSRealisation Plan Update, NAV and Dividend
31st Dec 20257:00 amRNSTotal Voting Rights
10th Dec 20252:27 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSThird Capital Distribution Update
26th Nov 20257:00 amRNSThird Compulsory Redemption & Dividend Declaration
11th Sep 20257:00 amRNSHalf-year Report
13th Aug 20257:00 amRNSInvestor report at 30 June 2025
24th Jul 20257:00 amRNSNet Asset Value and Dividend Declaration
20th Jun 20254:01 pmRNSHolding(s) in Company
6th Jun 202510:53 amRNSResults of Annual General Meeting
27th May 20252:05 pmRNSHolding(s) in Company
15th May 20254:30 pmRNSHolding(s) in Company
15th May 20254:28 pmRNSHolding(s) in Company
8th May 20259:30 amRNSNotice of Annual General Meeting
6th May 20251:10 pmRNSChange of Auditor
1st May 202510:21 amRNSDividend Declaration
30th Apr 20257:00 amRNSAnnual Report and Accounts
27th Feb 20257:00 amRNSInvestor report at 31 December 2024
12th Feb 20257:00 amRNSNet Asset Value and Dividend Declaration
4th Dec 20246:23 pmRNSHolding(s) in Company
29th Nov 20247:00 amRNSTotal Voting Rights
19th Nov 20241:33 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSSecond Capital Distribution Update
6th Nov 20246:20 pmRNSDividend & Second Compulsory Redemption
6th Nov 20247:00 amRNSDividend & Second Compulsory Redemption
18th Oct 20247:00 amRNSSecond Compulsory Redemption
19th Sep 20247:00 amRNSHalf-Yearly Report & Financial Statements
27th Aug 20247:00 amRNSInvestor report at 30 June 2024
30th Jul 20247:00 amRNSDividend Declaration
26th Jul 20247:00 amRNSQuarterly Update
23rd Jul 202410:56 amRNSDirector Declaration
8th Jul 20244:03 pmRNSLoan Repayment
4th Jul 20244:10 pmRNSPublication of Managed Realisation Plan
1st Jul 202412:23 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSTotal Voting Rights
11th Jun 20247:00 amRNSInitial Capital Distribution Update
7th Jun 20244:04 pmRNSCancellation of Shares held in Treasury
3rd Jun 20242:42 pmRNSLoan Repayment & Increased Return of Capital
30th May 20245:39 pmRNSDirector/PDMR Shareholding
29th May 20244:47 pmRNSForm 8.3 - GCP Asset Backed Income Fund Limited
29th May 20243:29 pmRNSForm 8.3 - GCP Asset Backed Income Fund Ltd
29th May 20242:01 pmRNSReturn of Capital & Conclusion of Strategic Review
28th May 20241:00 pmRNSForm 8.3 - GCP Asset Backed Income Fund Limited
28th May 202411:30 amRNSForm 8.3 - GCP Asset Backed Income Fund Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.